Clinical trials
Observational Pancreatic Neoplasms trials in France
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
44 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2004 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2011 | 1 |
| 2014 | 2 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 2 |
| 2019 | 3 |
| 2020 | 6 |
| 2021 | 4 |
| 2022 | 5 |
| 2023 | 2 |
| 2024 | 5 |
| 2025 | 2 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 18 |
| Recruiting | 10 |
| Unknown status | 10 |
| Not yet recruiting | 3 |
| Terminated | 2 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Institut Paoli-Calmettes | 5 |
| University Hospital, Montpellier | 4 |
| University Hospital, Strasbourg, France | 4 |
| Assistance Publique - Hôpitaux de Paris | 3 |
| Hospices Civils de Lyon | 3 |
| AstraZeneca | 2 |
| Fondation Hôpital Saint-Joseph | 2 |
| GCS Ramsay Santé pour l'Enseignement et la Recherche | 2 |
| Amgen | 1 |
| Celgene | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pancreatic Neoplasms | 44 |
| Colorectal Neoplasms | 7 |
| Stomach Neoplasms | 6 |
| Ovarian Neoplasms | 5 |
| Biliary Tract Neoplasms | 4 |
| Breast Neoplasms | 4 |
| Lung Neoplasms | 4 |
| Neoplasms | 4 |
| Adenocarcinoma | 3 |
| Esophageal Neoplasms | 3 |
Trials
Showing 1 to 25 of 44. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.